OAM
SRNE

Oxford Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Oxford Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,800
Closed -$45K – 2016
2019
Q2 		$45K Buy
+16,800
New +$60.5K ﹤0.01% 1640
2018
Q2 		– Sell
-53,727
Closed -$277K – 1990
2018
Q1 		$277K Sell
53,727
-161,874
-75% -$1.15M 0.01% 1424
2017
Q4 		$834K Buy
+215,601
New +$562K 0.02% 1006
2016
Q1 		– Sell
-26,699
Closed -$244K – 928
2015
Q4 		$244K Buy
+26,699
New +$225K 0.01% 775

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return